Green Cross induced 100 million dollars of foreign capitals.

Published: 2000-03-07 11:15:00

Updated: 2000-03-07 11:15:00

Green Cross made a strategic business tie-up with Rhein Biotech NV, a German multinational bio-engineering company and took a signature ceremony between Mr. Cho Ung-joon, the vice president of Green Cross and Dr. Daan Ellens, the CEO of Rhein Biotech at Maastricht in Netherland on March 1.

Green Cross splitted the stocks of Green Cross Vaccine by a spin-off and sold its 80% of shares to Rhei...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.